Senate Commerce Committee Statement to Senate, No. 2629 — State of New Jersey (March 16, 2026)
Summary
A Senate Commerce Committee statement to the Senate on Senate Bill No. 2629, State of New Jersey, dated March 16, 2026, reporting the bill favorably. The bill requires health insurance carriers, including insurance companies, health, hospital, and medical service corporations, and health maintenance organizations, to reimburse a health care provider that provides a vaccine at no less than the vaccine's Centers for Disease Control and Prevention (CDC) cost per dose rate under the CDC vaccine price list. The applicable rate is the one in effect on the date the vaccine was provided. The bill was prefiled for the 2026-2027 session and includes the changes required by technical review.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Senate Commerce Committee Statement to Senate, No. 2629 — State of New Jersey (March 16, 2026).”
Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/s2629-scm-statement-3-16-26-44cc0e04c0/
, SHA-256 5018a7a14bcdaabee7bde9891922d92dc34fe930ee97e90e874c8d9de510b72a.Full text
SENATE COMMERCE COMMITTEE STATEMENT TO SENATE, No. 2629 STATE OF NEW JERSEY DATED: MARCH 16, 2026 The Senate Commerce Committee reports favorably Senate Bill No. 2629. This bill requires health insurance carriers (including insurance companies, health, hospital, and medical service corporations, and health maintenance organizations) to reimburse a health care provider that provides a vaccine at a rate that is no less than the vaccine’s Centers for Disease Control and Prevention (CDC) cost per dose rate pursuant to the CDC vaccine price list. The CDC cost per dose rate is to be the rate in effect on the date the vaccine was provided. The CDC vaccine price list provides the CDC and private sector cost per dose contract prices for vaccines. This bill was prefiled for introduction in the 2026-2027 session pending technical review. As reported, the bill includes the changes required by technical review, which has been performed.
File and source
- File
- 2026-03-16_SCM_S2629_S1.htm
- Size
- 3,312 bytes
- SHA-256
- 5018a7a14bcdaabee7bde9891922d92dc34fe930ee97e90e874c8d9de510b72a
- Our copy
- 2026-03-16_SCM_S2629_S1.htm
- Original
- No public link identified.